Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,465 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.
Booth C, Sevilla J, Almarza E, Kuo CY, Zubicaray J, Terrazas D, O'Toole G, Chitty-Lopez M, Choi G, Nicoletti E, Long-Boyle J, Fernandes A, Chetty K, De Oliveira S, Banuelos C, Xu-Bayford J, Bastone AL, John-Neek P, Jackson C, Moore TB, Gilmour K, Schambach A, Rothe M, Kasbekar S, Rao GR, Patel K, Shah G, Thrasher AJ, Bueren JA, Schwartz JD, Kohn DB. Booth C, et al. Among authors: shah g. N Engl J Med. 2025 May 1;392(17):1698-1709. doi: 10.1056/NEJMoa2407376. N Engl J Med. 2025. PMID: 40305711 Clinical Trial.
Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease.
Greenberg B, Taylor M, Adler E, Colan S, Ricks D, Yarabe P, Battiprolu P, Shah G, Patel K, Coggins M, Carou-Keenan S, Schwartz JD, Rossano JW. Greenberg B, et al. Among authors: shah g. N Engl J Med. 2025 Mar 6;392(10):972-983. doi: 10.1056/NEJMoa2412392. Epub 2024 Nov 18. N Engl J Med. 2025. PMID: 39556016 Clinical Trial.
Systemic AAV9.LAMP2B injection reverses metabolic and physiologic multiorgan dysfunction in a murine model of Danon disease.
Manso AM, Hashem SI, Nelson BC, Gault E, Soto-Hermida A, Villarruel E, Brambatti M, Bogomolovas J, Bushway PJ, Chen C, Battiprolu P, Keravala A, Schwartz JD, Shah G, Gu Y, Dalton ND, Hammond K, Peterson K, Saftig P, Adler ED. Manso AM, et al. Among authors: shah g. Sci Transl Med. 2020 Mar 18;12(535):eaax1744. doi: 10.1126/scitranslmed.aax1744. Sci Transl Med. 2020. PMID: 32188720
Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell Transplant.
Eng S, Vadakkel G, Brown S, Murillo S, Fingrut W, Devlin S, Cook M, DeRespiris L, Lin A, Monaco-Cermak S, Nauffal M, Giralt SA, Perales MA, Barker J, Cho C, Walji M, Shah GL. Eng S, et al. Among authors: shah gl. Transplant Cell Ther. 2025 Jul 9:S2666-6367(25)01291-6. doi: 10.1016/j.jtct.2025.07.006. Online ahead of print. Transplant Cell Ther. 2025. PMID: 40645454
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies.
Einarsdottir S, Lobaugh S, Luan D, Gomez-Llobell M, Subramanian P, Devlin S, Chung D, Dahi PB, Falchi L, Giralt S, Landau H, Lesokhin AM, Lin R, Lue J, Mailankody S, Palomba ML, Park JH, Salles G, Scordo M, Escribano-Serrat S, Sanz J, Rejeski K, Shouval R, Usmani S, Perales MA, Shah G, Shahid Z. Einarsdottir S, et al. Among authors: shah g. Blood Cancer J. 2025 Jul 2;15(1):114. doi: 10.1038/s41408-025-01321-w. Blood Cancer J. 2025. PMID: 40603286 Free PMC article.
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience.
Cassanello G, Luttwak E, Brown S, Devlin SM, Imber B, Ip A, Leslie LA, Accav NG, Avigdor A, Marcus R, Beyar-Katz O, Corona M, Luna De Abia A, Calabrese De Feo J, Rivas Delgado A, Lue JK, Grommes C, Shah GL, Park J, Perales MA, Salles G, Shouval R, Scordo M, Palomba ML. Cassanello G, et al. Among authors: shah gl. Br J Haematol. 2025 Jul 1. doi: 10.1111/bjh.20234. Online ahead of print. Br J Haematol. 2025. PMID: 40589238
Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience.
Hultcrantz M, Derkach A, Hassoun H, Korde N, Maclachlan K, Mailankody S, Patel D, Shah UA, Tan CR, Chung DJ, Lahoud OB, Landau HJ, Scordo M, Shah GL, Nemirovsky D, Firestone RS, Akhlaghi T, Shekarkhand T, Giralt SA, Lesokhin AM, Usmani SZ. Hultcrantz M, et al. Among authors: shah gl. Blood Neoplasia. 2025 Apr 16;2(3):100103. doi: 10.1016/j.bneo.2025.100103. eCollection 2025 Aug. Blood Neoplasia. 2025. PMID: 40575079 Free PMC article.
1,465 results